Do You Qualify for Weight Loss Injections?
Eligibility, Options & What to Expect
Weight loss injections like Ozempic and Wegovy have transformed the landscape of medical weight management — but they're not suitable for everyone, and they're not a shortcut. If you've been wondering whether you qualify, this guide explains exactly who is eligible, how the medications work, and what the process looks like through e-Doctor's weight loss clinic.
What Are Weight Loss Injections?
Weight loss injections refer primarily to GLP-1 receptor agonists — a class of medications that mimic a naturally occurring hormone called glucagon-like peptide-1. This hormone plays a key role in regulating appetite, blood sugar, and how quickly food moves through your digestive system.
When used for weight loss, GLP-1 medications work by reducing hunger, increasing feelings of fullness, and helping your body process glucose more efficiently. The result — for most people — is a significant reduction in calorie intake and, over time, meaningful and sustained weight loss.
These are not diet pills. They are prescription medications that work on a biological level to address the hormonal drivers of appetite and weight gain.
Weight loss injections are prescription-only medications in Australia. They must be prescribed by a registered doctor following a clinical assessment. Medicare rebates do not currently apply to weight loss consultations or these medications through e-Doctor's program.
Who Qualifies for Weight Loss Injections?
GLP-1 medications are prescribed for weight management when the clinical benefits outweigh the risks. General eligibility criteria include:
- BMI of 30 or above — classified as obese, regardless of other health conditions
- BMI of 27 or above with a weight-related health condition — such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea, or polycystic ovarian syndrome (PCOS)
- Previous weight loss attempts — evidence that lifestyle changes alone have not produced sufficient results
- No contraindications — certain conditions or medications may make GLP-1 medications unsuitable (your doctor will assess this)
Likely Eligible
BMI 30+ or BMI 27+ with a related health condition. No history of medullary thyroid cancer or MEN2 syndrome. Not pregnant or breastfeeding.
Needs Assessment
History of pancreatitis, gallbladder disease, eating disorders, or certain gastrointestinal conditions. Your doctor will evaluate risk vs. benefit carefully.
Not Suitable
Personal or family history of medullary thyroid carcinoma or MEN2 syndrome. Currently pregnant or planning pregnancy. Some specific medication interactions.
The only way to know definitively whether you qualify is a clinical assessment with a doctor. e-Doctor's weight loss GPs conduct thorough consultations to assess your health history, current medications, and goals before recommending a treatment plan.
Available Medications in Australia
Several GLP-1 medications are currently available or approved in Australia for weight management:
- Semaglutide (Ozempic) — originally approved for type 2 diabetes, widely used off-label for weight loss; weekly injection. Currently experiencing supply constraints in Australia
- Semaglutide (Wegovy) — a higher-dose formulation of semaglutide approved specifically for chronic weight management; weekly injection
- Liraglutide (Saxenda) — a daily injection approved for weight management in Australia; slightly lower average weight loss than semaglutide but well-established
- Tirzepatide (Mounjaro) — a dual GIP/GLP-1 receptor agonist showing even greater weight loss results in clinical trials; availability in Australia is expanding
GLP-1 medications are not currently PBS-subsidised for weight loss in Australia, meaning they are paid for privately. Costs vary depending on the medication and dose. Your e-Doctor GP will discuss current availability and pricing during your consultation.
Book a weight loss consultation with an e-Doctor GP — no referral needed.
What to Expect on Treatment
GLP-1 medications are started at a low dose and gradually increased over several weeks or months to minimise side effects and allow your body to adjust. Here's what the typical experience looks like:
- Weeks 1–4 — low starting dose; most people notice reduced appetite and some nausea (usually mild and temporary). Initial weight loss begins
- Months 1–3 — dose titration continues; appetite suppression becomes more significant; consistent weight loss of 0.5–1kg per week is common
- Months 3–6 — approaching or at maintenance dose; weight loss continues, often accelerating; energy levels and metabolic markers typically improve
- 6–12+ months — maximum weight loss achieved in most people; focus shifts to maintaining results and building long-term habits
Common side effects include nausea, reduced appetite, constipation or loose stools, and fatigue — especially in the early weeks. These typically improve as your body adjusts. Serious side effects are uncommon but your doctor will monitor you throughout treatment.
How to Get Started with e-Doctor
Getting started is straightforward — no referral needed, no waiting rooms:
- Book a weight loss consultation with an e-Doctor GP via our online platform
- Your GP reviews your health history, BMI, current medications, and goals
- If appropriate, a prescription is issued and your personalised treatment plan is set out
- Ongoing follow-up consultations monitor your progress and adjust your dose as needed
e-Doctor's medical weight loss approach goes beyond prescribing medication — we integrate biomarker testing, body composition insights, and clinical expertise to give you the best possible foundation for lasting results.
